Nature Biotechnology's academic spinouts of 2014.

The article presents several short overviews of the science and technology chosen by the editors in 2014's crop of startups, which focuses on drug testing or therapies against rare disease, cancer, gastrointestinal disease, fibrosis and pain. Included topics are unum therapeutics as a universal cellular immunotherapy, voyager therapeutics and lysogene, and turning CRISPRs into drugs.